Wen Xu

Guangzhou University of Chinese Medicine — China

Medicine · Health Sciences

19h-index2.8kcitations46works60.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Cells and Metastasis(5), Liver physiology and pathology(4), Inflammasome and immune disorders(4), Cancer Genomics and Diagnostics(4), Schizophrenia research and treatment(3)

Publications46 total

Digital cognitive behavioral therapy as a novel treatment for insomnia
World Journal of Psychiatry·2025Open Access
NLRP3 inflammasome in neuroinflammation and central nervous system diseases
Cellular and Molecular Immunology·2025· 122 citedOpen Access
Shuhe granule for insomnia: study protocol for a double-blind, randomized, placebo-controlled trial
Frontiers in Pharmacology·2025Open Access
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
Science Advances·2024· 118 citedOpen Access
Tivantinib alleviates inflammatory diseases by directly targeting NLRP3
iScience·2023· 11 citedOpen Access
Characteristics of Prognostic Programmed Cell Death–Related Long Noncoding RNAs Associated With Immune Infiltration and Therapeutic Responses to Colon Cancer
Frontiers in Immunology·2022· 10 citedOpen Access
Regulation of Inflammatory Cell Death by Phosphorylation
Frontiers in Immunology·2022· 32 citedOpen Access
NLRP3 inflammasome activation and cell death
Cellular and Molecular Immunology·2021· 1.4k citedOpen Access
Depichering the Effects of Astragaloside IV on AD‐Like Phenotypes: A Systematic and Experimental Investigation
Oxidative Medicine and Cellular Longevity·2021· 29 citedOpen Access
Abstract 4188: The ERK1/2 inhibitor, JSI-1187, demonstrates preclinical efficacy in tumor models with MAPK pathway mutations
Cancer Research·2020· 6 cited
Astragaloside IV prevents Aβ1-42 oligomers-induced memory impairment and hippocampal cell apoptosis by promoting PPARγ/BDNF signaling pathway
Brain Research·2020· 58 cited
<p>Efficacy of low-dose D<sub>2</sub>/D<sub>3</sub> partial agonist pramipexole on neuroleptic-induced extrapyramidal symptoms and symptoms of schizophrenia: a stage-1 open-label pilot study</p>
Neuropsychiatric Disease and Treatment·2019· 6 citedOpen Access
Basolateral amygdala calpain is required for extinction of contextual fear-memory
Neurobiology of Learning and Memory·2018· 26 cited
GPR30 activation improves memory and facilitates DHPG-induced LTD in the hippocampal CA3 of middle-aged mice
Neurobiology of Learning and Memory·2018· 34 cited
Clinicopathological parameters associated with histological background and recurrence after surgical intervention of vocal cord leukoplakia
Medicine·2017· 33 citedOpen Access
Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers
Journal of Cancer Research and Therapeutics·2016· 12 citedOpen Access
[Diagnosis and treatment of laryngeal leukoplakia].
PubMed·2015· 1 cited
The relationship between mast cells-associated antibodies and molecules and autoimmune liver disease
Zhonghua jianyan yixue zazhi·2015
[The clinical application of data mining in laryngeal cancer].
PubMed·2015· 1 cited
Implementing a protocol for vitamin D screening and replacement in cancer patients
Queensland's institutional digital repository (The University of Queensland)·2014
page 1 of 3Next →

Frequent Co-authors

Zhengfeng Yin(7), Yi Huang(5), Lu Cao(4), Jian Liao(4), Haihua Qian(4), Guoqi Zhu(4), Yanming Zhou(3), Ruixiu Zhang(3), Mengchao Wu(3), Hui Qian(3), Olawale Osuntokun(3), Rongbin Zhou(2), Yu Zhang(2), Yi Ru(2), Ying‐Li Luo(2), Fei Mao(2), John M. Kane(2), Ludmila Kryzhanovskaya(2), Virginia L. Stauffer(2), Xuncui Wang(2)